Disease Areas Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery Second Genome aims to identify a composite biomarker for the noninvasive diagnosis of nonalcoholic steatohepatitis patients with advanced fibrosis. Aviv Scientific Closes $40M Series B Financing Round The company plans to use the funds to roll out a database containing comprehensive omics data that captures the aging process in healthy adults. Genomenon, Alexion Pharmaceuticals Team on Rare Disease Dx Genomenon will apply its AI-driven technology to develop a "genomic landscape" for specific conditions and combine those data with therapy and trial information. DiaSorin Molecular Receives CE Mark for Multiplex COVID-19, Influenza Test The test detects and differentiates between nucleic acids from SARS-CoV-2 and influenza A/B from the same sample in one reaction well. New Facial Analysis Tool From Children's National Hospital Screens for Genetic Diseases Premium The technology has been licensed by MGeneRx, which plans to commercialize it in the US first, then expand to low- and middle-income countries. Sep 16, 2021 Polygenic Risk Scores for Breast, Prostate Cancer Adaptable for Cross-Ancestry Use, Study Shows Sep 16, 2021 Molecular Clonal Tracking Method Captures Lung Cancer Treatment Response, Resistance Features Sep 16, 2021 Thermo Fisher Scientific Receives CE Mark for TaqPath COVID-19 RNase P 2.0 Testing Kit Sep 16, 2021 Castle Biosciences Receives New York State Approval for DecisionDx DiffDx-Melanoma Test Sep 16, 2021 FDA Approves Takeda's Exkivity With Thermo Fisher CDx for EGFR Exon20 Insertion-Positive NSCLC Sep 15, 2021 2021 Ebola Outbreak Resulted From Viral Latency, Reactivation, Genomic Study Finds Sep 15, 2021 Sensorion, Sonova Partner for €7M Hearing Loss Genotyping Study Sep 15, 2021 Broad Institute, Novo Nordisk Foundation Launch Center to Study Genomic Mechanisms of Disease Sep 14, 2021 Centenarian Exome Analysis Points to Conserved Longevity Pathways Sep 14, 2021 Updated Cepheid SARS-CoV-2, Flu, RSV Test Nabs FDA EUA Sep 14, 2021 Exact Sciences, NSABP Validating Ability of ctDNA Test to Detect MRD in Colorectal Cancer Patients Sep 13, 2021 Immunovia, JW BioScience Ink Licensing Agreement for Early Pancreatic Cancer Detection Biomarkers Sep 10, 2021 Japanese Health Ministry Clears Thermo Fisher Scientific Oncomine Assay as CDx for Lung Cancer Drug Sep 9, 2021 UK Startup Presymptom Health Developing Host-Response Prognostic Test for Sepsis Premium Sep 9, 2021 Invivoscribe Enters Bioinformatics Market, Hires First CIO Premium Sep 9, 2021 Blueprint Genetics to Analyze Biobank Samples for Rare Diseases in New Finnish Study Sep 8, 2021 Natera Signatera Test to be Used in Study of MRD-Guided Treatment for Colon Cancer Patients Sep 7, 2021 CSIRO Develops Software to Detect Foreign DNA Without Reference Genomes Premium Sep 7, 2021 Polygenic Risk Score Addition Does Not Improve Models Predicting Schizophrenia Prognosis Sep 7, 2021 Centogene Q2 Revenues Continue to Benefit From COVID-19 Testing as Core Business Starts to Recover Load More Breaking News Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design NIH Awards $73M to Continue Buildout of ClinGen The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.